Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor Use

被引:5
作者
Akturk, Halis K. [1 ]
Sakamoto, Casey [1 ]
Vigers, Tim [1 ]
Shah, Viral N. [1 ]
Pyle, Laura [1 ]
机构
[1] Univ Colorado, Barbara Davis Ctr Diabet, Aurora, CO USA
关键词
type; 1; diabetes; continuous glucose monitoring; time in range; optimal sampling; INTERNATIONAL CONSENSUS; ADULTS;
D O I
10.1177/19322968231200901
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Two weeks of continuous glucose monitoring (CGM) sampling with >70% CGM use is recommended to accurately reflect 90 days of glycemic metrics. However, minimum sampling duration for CGM use <70% is not well studied. We investigated the minimum duration of CGM sampling required for each CGM metric to achieve representative glycemic outcomes for <70% CGM use over 90 days. Methods: Ninety days of CGM data were collected in 336 real-life CGM users with type 1 diabetes. CGM data were grouped in 5% increments of CGM use (45%-95%) over 90 days. For each CGM metric and each CGM use category, the correlation between the summary statistic calculated using each sampling period and all 90 days of data was determined using the squared value of the Spearmen correlation coefficient (R-2). Results: For CGM use 45% to 95% over 90 days, minimum sampling period is 14 days for mean glucose, time in range (70-180 mg/dL), time >180 mg/dL, and time >250 mg/dL; 28 days for coefficient of variation, and 35 days for time <54 mg/dL. For time <70 mg/dL, 28 days is sufficient between 45 and 80% CGM use, while 21 days is required >80% CGM use. Conclusion: We defined minimum sampling durations for all CGM metrics in suboptimal CGM use. CGM sampling of at least 14 days is required for >45% CGM use over 90 days to sufficiently reflect most of the CGM metrics. Assessment of hypoglycemia and coefficient of variation require a longer sampling period regardless of CGM use duration.
引用
收藏
页码:345 / 351
页数:7
相关论文
共 50 条
[41]   Prediction of Adverse Glycemic Events From Continuous Glucose Monitoring Signal [J].
Gadaleta, Matteo ;
Facchinetti, Andrea ;
Grisan, Enrico ;
Rossi, Michele .
IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2019, 23 (02) :650-659
[42]   Continuous Glucose Monitoring in Hospitalized Patients With Type 2 Diabetes: A Step Forward in Inpatient Glycemic Control [J].
Rivas-Montenegro, Alejandra ;
Anez-Ramos, Roberto ;
Pastor, Alba Galdon-Sanz ;
Gonzalez-Albarran, Olga .
ENDOCRINE PRACTICE, 2025, 31 (05) :564-570
[43]   Early Continuous Glucose Monitor Use in Children and Adolescents With Type 1 Diabetes: Rates of Initiation and Impact on Glycemic Outcomes [J].
Mann, Elizabeth A. ;
Rompicherla, Saketh ;
Miyazaki, Brian ;
Rioles, Nicole ;
Hardison, Holly ;
Golden, Lauren ;
Sarhis, Jennifer ;
Akturk, Halis K. ;
Lee, Joyce ;
Desalvo, Daniel J. ;
Gomez, Patricia ;
Ebekozien, Osagie ;
Prahalad, Priya .
DIABETES CARE, 2025, 48 (05) :768-775
[44]   Feasibility of Using Continuous Glucose Monitoring to Detect Glycemic Abnormalities in Children with Cystic Fibrosis [J].
Leonard, Amanda ;
Judware, Isabel R. ;
Vanscoy, Lori L. ;
Paranjape, Shruti M. ;
Peeler, Donna ;
Wu, Malinda ;
Blackman, Scott M. ;
Mogayzel, Peter J. .
HORMONE RESEARCH IN PAEDIATRICS, 2024,
[45]   Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring [J].
Legris, Pauline ;
Bouillet, Benjamin ;
Paris, Justine ;
Pistre, Pauline ;
Devaux, Madeline ;
Bost, Stephanie ;
Simoneau, Isabelle ;
Manfredi, Sylvain ;
Drouillard, Antoine ;
Bastie, Jean-Noel ;
Chaix, Marie ;
Massoud, Pamela ;
Rouland, Alexia ;
Aho, Serge ;
Boulin, Mathieu ;
Petit, Jean-Michel .
ACTA DIABETOLOGICA, 2023, 60 (04) :545-552
[46]   Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD [J].
Presswala, Lubaina ;
Hong, Susana ;
Harris, Yael ;
Romao, Isabela ;
Zhang, Meng ;
Jhaveri, Kenar D. ;
Sakhiya, Vipul ;
Fishbane, Steven .
KIDNEY MEDICINE, 2019, 1 (05) :281-287
[47]   Relationship between blood glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics: Subanalysis of a prospective cohort study [J].
Tokutsu, Akemi ;
Okada, Yosuke ;
Mita, Tomoya ;
Torimoto, Keiichi ;
Wakasugi, Satomi ;
Katakami, Naoto ;
Yoshii, Hidenori ;
Uryu, Kohei ;
Nishida, Keiko ;
Arao, Tadashi ;
Tanaka, Yoshiya ;
Gosho, Masahiko ;
Shimomura, Iichiro ;
Watada, Hirotaka .
DIABETES OBESITY & METABOLISM, 2022, 24 (01) :82-93
[48]   Intra-pancreatic fat is associated with continuous glucose monitoring metrics [J].
Liu, Yutong ;
Kimita, Wandia ;
Shamaitijiang, Xiatiguli ;
Skudder-Hill, Loren ;
Sequeira-Bisson, Ivana R. ;
Petrov, Maxim S. .
DIABETES OBESITY & METABOLISM, 2024, 26 (06) :2359-2367
[49]   Glycemic variability of acute stroke patients and clinical outcomes: a continuous glucose monitoring study [J].
Palaiodimou, Lina ;
Lioutas, Vasileios-Arsenios ;
Lambadiari, Vaia ;
Theodorou, Aikaterini ;
Themistocleous, Marios ;
Aponte, Laura ;
Papagiannopoulou, Georgia ;
Foska, Aikaterini ;
Bakola, Eleni ;
Quispe, Rodrigo ;
Mendez, Laura ;
Selim, Magdy ;
Novak, Vera ;
Tzavellas, Elias ;
Halvatsiotis, Panagiotis ;
Voumvourakis, Konstantinos ;
Tsivgoulis, Georgios .
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
[50]   Relationships of hypoglycemia awareness, hypoglycemia beliefs, and continuous glucose monitoring glycemic profiles with anxiety and depression symptoms in adults with type 1 diabetes using continuous glucose monitoring systems [J].
Lin, Yu Kuei ;
Hepworth, Emily ;
de Zoysa, Nicole ;
Mccurley, Jessica ;
Vajravelu, Mary Ellen ;
Ye, Wen ;
Piatt, Gretchen A. ;
Amiel, Stephanie A. ;
Fisher, Simon J. ;
Pop-Busui, Rodica ;
Aikens, James E. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209